DocGo Q3 Revenue $73.4M, Net Loss $18.1M; CEO Search Launched, 2026 Revenue Guidance Cut
DCGO sits 18% above its 52-week low of $0.209.
Summary
DocGo reported Q3 revenue of $73.4 million and a net loss of $18.1 million, cut 2026 revenue guidance to about $300 million, and announced a CEO search as Lee Bienstock's contract expires at year-end.
Key Events · Earnings and Guidance · DCGO
-
Q3 Results: Revenue Up, Loss Narrows
Total revenue was $73.4 million versus $70.8 million a year ago; net loss was $18.1 million versus $29.7 million, and adjusted EBITDA loss narrowed to $(3.2) million from $(7.2) million.
-
2026 Revenue Guidance Cut
Full-year 2026 revenue is now expected at approximately $300 million, down from prior guidance of $305-$310 million, due to elimination and restructuring of unprofitable business lines; adjusted EBITDA guidance held at $(17)-$(22) million.
-
CEO Search Launched
The Board began a search, led by Heidrick & Struggles, as CEO Lee Bienstock's employment contract expires December 31, 2026; Bienstock will remain through at least March 31, 2027.
-
Cash Falls to $19.1 Million
Unrestricted cash was $19.1 million at September 30, 2026, down from $25.2 million at June 30, 2026, and excludes the Perceptive Advisors debt funding received October 1, 2026.
Analysis · DCGO · Energy & Transportation
Margin progress is real: GAAP gross margin jumped to 29.7% from 20.0% a year ago, and the adjusted EBITDA loss narrowed to $(3.2) million from $(7.2) million. But the company also cut full-year 2026 revenue guidance to about $300 million from $305-$310 million and disclosed that its CEO will depart when his contract expires December 31, 2026. With only $19.1 million of unrestricted cash at quarter-end and a going-concern warning previously disclosed in the Q2 10-Q, the combination of a leadership vacuum, shrinking revenue base and thin liquidity is what matters here. The pending Hicuity Health acquisition, expected to close in late November or early December, adds execution risk on top of the transition.
How filings like this one have moved
In the 30 days to Nov 9, 2026, 47.1% of the 1533 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DCGO was trading at $0.25 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $24.9M. The 52-week trading range was $0.21 to $1.17. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.